Komori
M&A and Subsidiary Changes9245Livero Inc.Information and Communications, Services and Others

Notice regarding an accumulation of shares specified by Cabinet Order as an act equivalent to a tender offer for Livero Inc. (Securities Code: 9245)

株式会社HITEN acquired 350,000 shares of Livero Inc. from its Representative Director and President, Kashima Hidetoshi (鹿島秀俊), and now holds 6.56% of the voting rights. 株式会社HITEN plans to hold the shares long term as a stable shareholder.

Worth reading
22Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
6.56
%
Wording
Definitive
How definitive the wording is.

This transaction

Accumulation of shares prescribed by Cabinet Order as an act equivalent to a tender offer
Counterparty株式会社HITEN, Kashima Hidetoshi (鹿島秀俊)
Disclosing companyLivero Inc.
Livero Inc.Voting rights ownership percentageNumber of shares acquired 350,000 shares; number of voting rights: Not disclosed

The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.

Execution Date / Effective Date30 September 2026
This transaction
ItemDetails
Transaction nameAccumulation of shares prescribed by Cabinet Order as an act equivalent to a tender offer
Counterparty name株式会社HITEN, Kashima Hidetoshi (鹿島秀俊)
Name of the Subject CompanyLivero Inc.
Number of shares acquired350,000 shares; number of voting rights: Not disclosed
Voting rights ownership percentageAfter 6.56% (before not disclosed)
Execution Date / Effective Date30 September 2026
Items this document does not state (26)
Business Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Impact on Business PerformanceDate of board resolutionContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The purpose is to hold the shares long term as a stable shareholder.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice regarding an accumulation of shares specified by Cabinet Order as an act equivalent to a tender offer for Livero Inc. (Securities Code: 9245) | Livero Inc. (9245) timely disclosure | Komori